In order to evaluate the potential clinical relevance of the DIN central hubs, retrospective analyses of the correlation among CEBP-β, PLK1, ATF3, EPAS1, and CEPB-zeta (DDIT3) levels and overall survival (OS) in patients with BC were conducted (Figure 4). Here, EPAS1 is linked to breast cancer.